ReviewFrontiers in neurology
Current status and advances in comprehensive treatment of acute ischemic stroke in China: from evidence-based guidelines to clinical practice.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The leading cause of death and disability in Chinese residents is acute ischemic stroke (AIS). Standardized comprehensive treatment is essential for improving AIS outcomes. This article provides a systems-level analysis of the comprehensive treatment system of AIS in China by integrating evidence-based clinical guidelines, real-world clinical practice data and national medical quality control results, reviews the complete process from pre-hospital emergency care to ultra-early reperfusion therapy (intravenous thrombolysis and endovascular treatment) to the management of acute-phase complications to secondary prevention and rehabilitation. The article integrates the latest clinical research data, current diagnostic and treatment guidelines and medical quality control report in China, carries out a critical analysis on the strengths, weaknesses and regional imbalance of current treatment models by grading the evidence strength of different research types (randomized controlled trials, observational studies, guidelines and meta-analyses), and elaborates on future development direction which can serve as reference to improve overall treatment level of AIS in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.